Global and Japan Liposome Assisted Drug Delivery Market Size, Status and Forecast 2024-2031

Report ID: 1023613 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Liposomal Doxorubicin
        1.2.3 Liposomal Amphoteracin B
        1.2.4 Liposomal Paclitaxel
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Liposome Assisted Drug Delivery Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Fungal Infection Therapy
        1.3.3 Cancer & Tumor Therapy
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Liposome Assisted Drug Delivery Market Perspective (2016-2027)
    2.2 Liposome Assisted Drug Delivery Growth Trends by Regions
        2.2.1 Liposome Assisted Drug Delivery Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Liposome Assisted Drug Delivery Historic Market Share by Regions (2016-2021)
        2.2.3 Liposome Assisted Drug Delivery Forecasted Market Size by Regions (2022-2027)
    2.3 Liposome Assisted Drug Delivery Industry Dynamic
        2.3.1 Liposome Assisted Drug Delivery Market Trends
        2.3.2 Liposome Assisted Drug Delivery Market Drivers
        2.3.3 Liposome Assisted Drug Delivery Market Challenges
        2.3.4 Liposome Assisted Drug Delivery Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Liposome Assisted Drug Delivery Players by Revenue
        3.1.1 Global Top Liposome Assisted Drug Delivery Players by Revenue (2016-2021)
        3.1.2 Global Liposome Assisted Drug Delivery Revenue Market Share by Players (2016-2021)
    3.2 Global Liposome Assisted Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Liposome Assisted Drug Delivery Revenue
    3.4 Global Liposome Assisted Drug Delivery Market Concentration Ratio
        3.4.1 Global Liposome Assisted Drug Delivery Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Liposome Assisted Drug Delivery Revenue in 2020
    3.5 Liposome Assisted Drug Delivery Key Players Head office and Area Served
    3.6 Key Players Liposome Assisted Drug Delivery Product Solution and Service
    3.7 Date of Enter into Liposome Assisted Drug Delivery Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Liposome Assisted Drug Delivery Breakdown Data by Type
    4.1 Global Liposome Assisted Drug Delivery Historic Market Size by Type (2016-2021)
    4.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2022-2027)

5 Liposome Assisted Drug Delivery Breakdown Data by Application
    5.1 Global Liposome Assisted Drug Delivery Historic Market Size by Application (2016-2021)
    5.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Liposome Assisted Drug Delivery Market Size (2016-2027)
    6.2 North America Liposome Assisted Drug Delivery Market Size by Type
        6.2.1 North America Liposome Assisted Drug Delivery Market Size by Type (2016-2021)
        6.2.2 North America Liposome Assisted Drug Delivery Market Size by Type (2022-2027)
        6.2.3 North America Liposome Assisted Drug Delivery Market Size by Type (2016-2027)
    6.3 North America Liposome Assisted Drug Delivery Market Size by Application
        6.3.1 North America Liposome Assisted Drug Delivery Market Size by Application (2016-2021)
        6.3.2 North America Liposome Assisted Drug Delivery Market Size by Application (2022-2027)
        6.3.3 North America Liposome Assisted Drug Delivery Market Size by Application (2016-2027)
    6.4 North America Liposome Assisted Drug Delivery Market Size by Country
        6.4.1 North America Liposome Assisted Drug Delivery Market Size by Country (2016-2021)
        6.4.2 North America Liposome Assisted Drug Delivery Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Liposome Assisted Drug Delivery Market Size (2016-2027)
    7.2 Europe Liposome Assisted Drug Delivery Market Size by Type
        7.2.1 Europe Liposome Assisted Drug Delivery Market Size by Type (2016-2021)
        7.2.2 Europe Liposome Assisted Drug Delivery Market Size by Type (2022-2027)
        7.2.3 Europe Liposome Assisted Drug Delivery Market Size by Type (2016-2027)
    7.3 Europe Liposome Assisted Drug Delivery Market Size by Application
        7.3.1 Europe Liposome Assisted Drug Delivery Market Size by Application (2016-2021)
        7.3.2 Europe Liposome Assisted Drug Delivery Market Size by Application (2022-2027)
        7.3.3 Europe Liposome Assisted Drug Delivery Market Size by Application (2016-2027)
    7.4 Europe Liposome Assisted Drug Delivery Market Size by Country
        7.4.1 Europe Liposome Assisted Drug Delivery Market Size by Country (2016-2021)
        7.4.2 Europe Liposome Assisted Drug Delivery Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Liposome Assisted Drug Delivery Market Size (2016-2027)
    8.2 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Type
        8.2.1 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Type (2016-2027)
    8.3 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Application
        8.3.1 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Application (2016-2027)
    8.4 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region
        8.4.1 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Liposome Assisted Drug Delivery Market Size (2016-2027)
    9.2 Latin America Liposome Assisted Drug Delivery Market Size by Type
        9.2.1 Latin America Liposome Assisted Drug Delivery Market Size by Type (2016-2021)
        9.2.2 Latin America Liposome Assisted Drug Delivery Market Size by Type (2022-2027)
        9.2.3 Latin America Liposome Assisted Drug Delivery Market Size by Type (2016-2027)
    9.3 Latin America Liposome Assisted Drug Delivery Market Size by Application
        9.3.1 Latin America Liposome Assisted Drug Delivery Market Size by Application (2016-2021)
        9.3.2 Latin America Liposome Assisted Drug Delivery Market Size by Application (2022-2027)
        9.3.3 Latin America Liposome Assisted Drug Delivery Market Size by Application (2016-2027)
    9.4 Latin America Liposome Assisted Drug Delivery Market Size by Country
        9.4.1 Latin America Liposome Assisted Drug Delivery Market Size by Country (2016-2021)
        9.4.2 Latin America Liposome Assisted Drug Delivery Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Liposome Assisted Drug Delivery Market Size (2016-2027)
    10.2 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Type
        10.2.1 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Type (2016-2027)
    10.3 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Application
        10.3.1 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Application (2016-2027)
    10.4 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country
        10.4.1 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Gilead Sciences
        11.1.1 Gilead Sciences Company Details
        11.1.2 Gilead Sciences Business Overview
        11.1.3 Gilead Sciences Liposome Assisted Drug Delivery Introduction
        11.1.4 Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.1.5 Gilead Sciences Recent Development
    11.2 Pacira
        11.2.1 Pacira Company Details
        11.2.2 Pacira Business Overview
        11.2.3 Pacira Liposome Assisted Drug Delivery Introduction
        11.2.4 Pacira Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.2.5 Pacira Recent Development
    11.3 Sun Pharmaceutical
        11.3.1 Sun Pharmaceutical Company Details
        11.3.2 Sun Pharmaceutical Business Overview
        11.3.3 Sun Pharmaceutical Liposome Assisted Drug Delivery Introduction
        11.3.4 Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.3.5 Sun Pharmaceutical Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Liposome Assisted Drug Delivery Introduction
        11.4.4 Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Luye Pharma
        11.5.1 Luye Pharma Company Details
        11.5.2 Luye Pharma Business Overview
        11.5.3 Luye Pharma Liposome Assisted Drug Delivery Introduction
        11.5.4 Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.5.5 Luye Pharma Recent Development
    11.6 Sigma-Tau Group
        11.6.1 Sigma-Tau Group Company Details
        11.6.2 Sigma-Tau Group Business Overview
        11.6.3 Sigma-Tau Group Liposome Assisted Drug Delivery Introduction
        11.6.4 Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.6.5 Sigma-Tau Group Recent Development
    11.7 Ipsen (Onivyde)
        11.7.1 Ipsen (Onivyde) Company Details
        11.7.2 Ipsen (Onivyde) Business Overview
        11.7.3 Ipsen (Onivyde) Liposome Assisted Drug Delivery Introduction
        11.7.4 Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.7.5 Ipsen (Onivyde) Recent Development
    11.8 CSPC
        11.8.1 CSPC Company Details
        11.8.2 CSPC Business Overview
        11.8.3 CSPC Liposome Assisted Drug Delivery Introduction
        11.8.4 CSPC Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.8.5 CSPC Recent Development
    11.9 Teva Pharmaceutical
        11.9.1 Teva Pharmaceutical Company Details
        11.9.2 Teva Pharmaceutical Business Overview
        11.9.3 Teva Pharmaceutical Liposome Assisted Drug Delivery Introduction
        11.9.4 Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.9.5 Teva Pharmaceutical Recent Development
    11.10 Novartis
        11.10.1 Novartis Company Details
        11.10.2 Novartis Business Overview
        11.10.3 Novartis Liposome Assisted Drug Delivery Introduction
        11.10.4 Novartis Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.10.5 Novartis Recent Development
    11.11 Fudan-Zhangjiang
        11.11.1 Fudan-Zhangjiang Company Details
        11.11.2 Fudan-Zhangjiang Business Overview
        11.11.3 Fudan-Zhangjiang Liposome Assisted Drug Delivery Introduction
        11.11.4 Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2016-2021)
        11.11.5 Fudan-Zhangjiang Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Liposomal Doxorubicin
    Table 3. Key Players of Liposomal Amphoteracin B
    Table 4. Key Players of Liposomal Paclitaxel
    Table 5. Key Players of Others
    Table 6. Global Liposome Assisted Drug Delivery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Liposome Assisted Drug Delivery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Liposome Assisted Drug Delivery Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Liposome Assisted Drug Delivery Market Share by Regions (2016-2021)
    Table 10. Global Liposome Assisted Drug Delivery Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Liposome Assisted Drug Delivery Market Share by Regions (2022-2027)
    Table 12. Liposome Assisted Drug Delivery Market Trends
    Table 13. Liposome Assisted Drug Delivery Market Drivers
    Table 14. Liposome Assisted Drug Delivery Market Challenges
    Table 15. Liposome Assisted Drug Delivery Market Restraints
    Table 16. Global Liposome Assisted Drug Delivery Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Liposome Assisted Drug Delivery Market Share by Players (2016-2021)
    Table 18. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposome Assisted Drug Delivery as of 2020)
    Table 19. Ranking of Global Top Liposome Assisted Drug Delivery Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Liposome Assisted Drug Delivery Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Liposome Assisted Drug Delivery Product Solution and Service
    Table 23. Date of Enter into Liposome Assisted Drug Delivery Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Liposome Assisted Drug Delivery Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2016-2021)
    Table 27. Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Liposome Assisted Drug Delivery Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Liposome Assisted Drug Delivery Revenue Market Share by Application (2016-2021)
    Table 31. Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Liposome Assisted Drug Delivery Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Liposome Assisted Drug Delivery Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Liposome Assisted Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Liposome Assisted Drug Delivery Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Liposome Assisted Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Liposome Assisted Drug Delivery Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Liposome Assisted Drug Delivery Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Liposome Assisted Drug Delivery Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Liposome Assisted Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Liposome Assisted Drug Delivery Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Liposome Assisted Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Liposome Assisted Drug Delivery Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Liposome Assisted Drug Delivery Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Liposome Assisted Drug Delivery Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Liposome Assisted Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Liposome Assisted Drug Delivery Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Liposome Assisted Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Liposome Assisted Drug Delivery Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Liposome Assisted Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Liposome Assisted Drug Delivery Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Liposome Assisted Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Liposome Assisted Drug Delivery Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Liposome Assisted Drug Delivery Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Liposome Assisted Drug Delivery Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Liposome Assisted Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Liposome Assisted Drug Delivery Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Liposome Assisted Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Gilead Sciences Company Details
    Table 64. Gilead Sciences Business Overview
    Table 65. Gilead Sciences Liposome Assisted Drug Delivery Product
    Table 66. Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 67. Gilead Sciences Recent Development
    Table 68. Pacira Company Details
    Table 69. Pacira Business Overview
    Table 70. Pacira Liposome Assisted Drug Delivery Product
    Table 71. Pacira Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 72. Pacira Recent Development
    Table 73. Sun Pharmaceutical Company Details
    Table 74. Sun Pharmaceutical Business Overview
    Table 75. Sun Pharmaceutical Liposome Assisted Drug Delivery Product
    Table 76. Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 77. Sun Pharmaceutical Recent Development
    Table 78. Johnson & Johnson Company Details
    Table 79. Johnson & Johnson Business Overview
    Table 80. Johnson & Johnson Liposome Assisted Drug Delivery Product
    Table 81. Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 82. Johnson & Johnson Recent Development
    Table 83. Luye Pharma Company Details
    Table 84. Luye Pharma Business Overview
    Table 85. Luye Pharma Liposome Assisted Drug Delivery Product
    Table 86. Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 87. Luye Pharma Recent Development
    Table 88. Sigma-Tau Group Company Details
    Table 89. Sigma-Tau Group Business Overview
    Table 90. Sigma-Tau Group Liposome Assisted Drug Delivery Product
    Table 91. Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 92. Sigma-Tau Group Recent Development
    Table 93. Ipsen (Onivyde) Company Details
    Table 94. Ipsen (Onivyde) Business Overview
    Table 95. Ipsen (Onivyde) Liposome Assisted Drug Delivery Product
    Table 96. Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 97. Ipsen (Onivyde) Recent Development
    Table 98. CSPC Company Details
    Table 99. CSPC Business Overview
    Table 100. CSPC Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 101. CSPC Recent Development
    Table 102. Teva Pharmaceutical Company Details
    Table 103. Teva Pharmaceutical Business Overview
    Table 104. Teva Pharmaceutical Liposome Assisted Drug Delivery Product
    Table 105. Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 106. Teva Pharmaceutical Recent Development
    Table 107. Novartis Company Details
    Table 108. Novartis Business Overview
    Table 109. Novartis Liposome Assisted Drug Delivery Product
    Table 110. Novartis Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 111. Novartis Recent Development
    Table 112. Fudan-Zhangjiang Company Details
    Table 113. Fudan-Zhangjiang Business Overview
    Table 114. Fudan-Zhangjiang Liposome Assisted Drug Delivery Product
    Table 115. Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2016-2021) & (US$ Million)
    Table 116. Fudan-Zhangjiang Recent Development
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Liposome Assisted Drug Delivery Market Share by Type: 2020 VS 2027
    Figure 2. Liposomal Doxorubicin Features
    Figure 3. Liposomal Amphoteracin B Features
    Figure 4. Liposomal Paclitaxel Features
    Figure 5. Others Features
    Figure 6. Global Liposome Assisted Drug Delivery Market Share by Application: 2020 VS 2027
    Figure 7. Fungal Infection Therapy Case Studies
    Figure 8. Cancer & Tumor Therapy Case Studies
    Figure 9. Others Case Studies
    Figure 10. Liposome Assisted Drug Delivery Report Years Considered
    Figure 11. Global Liposome Assisted Drug Delivery Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Liposome Assisted Drug Delivery Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Liposome Assisted Drug Delivery Market Share by Regions: 2020 VS 2027
    Figure 14. Global Liposome Assisted Drug Delivery Market Share by Regions (2022-2027)
    Figure 15. Global Liposome Assisted Drug Delivery Market Share by Players in 2020
    Figure 16. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposome Assisted Drug Delivery as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Liposome Assisted Drug Delivery Revenue in 2020
    Figure 18. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2016-2021)
    Figure 19. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2022-2027)
    Figure 20. North America Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Liposome Assisted Drug Delivery Market Share by Type (2016-2027)
    Figure 22. North America Liposome Assisted Drug Delivery Market Share by Application (2016-2027)
    Figure 23. North America Liposome Assisted Drug Delivery Market Share by Country (2016-2027)
    Figure 24. United States Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Liposome Assisted Drug Delivery Market Share by Type (2016-2027)
    Figure 28. Europe Liposome Assisted Drug Delivery Market Share by Application (2016-2027)
    Figure 29. Europe Liposome Assisted Drug Delivery Market Share by Country (2016-2027)
    Figure 30. Germany Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Liposome Assisted Drug Delivery Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Liposome Assisted Drug Delivery Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Liposome Assisted Drug Delivery Market Share by Region (2016-2027)
    Figure 40. China Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Liposome Assisted Drug Delivery Market Share by Type (2016-2027)
    Figure 48. Latin America Liposome Assisted Drug Delivery Market Share by Application (2016-2027)
    Figure 49. Latin America Liposome Assisted Drug Delivery Market Share by Country (2016-2027)
    Figure 50. Mexico Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Liposome Assisted Drug Delivery Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Liposome Assisted Drug Delivery Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Liposome Assisted Drug Delivery Market Share by Country (2016-2027)
    Figure 56. Turkey Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Liposome Assisted Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Gilead Sciences Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 60. Pacira Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 61. Sun Pharmaceutical Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 62. Johnson & Johnson Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 63. Luye Pharma Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 64. Sigma-Tau Group Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 65. Ipsen (Onivyde) Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 66. CSPC Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 67. Teva Pharmaceutical Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 68. Novartis Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 69. Fudan-Zhangjiang Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Frequently Asked Questions
Liposome Assisted Drug Delivery report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Liposome Assisted Drug Delivery report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Liposome Assisted Drug Delivery report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports